← Open Payments lookup

NATASHA RADOJCIC: Open Payments

NPI 1982465837 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,918 in 26 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,918

Food & beverage: $1,918
CompanyPaymentsAmount
Janssen Biotech, Inc.7$487
Daiichi Sankyo Inc.9$308
AstraZeneca Pharmaceuticals LP2$214
ABBVIE INC.2$166
BeOne Medicines USA, Inc.1$133
Stemline Therapeutics Inc.1$125
Incyte Corporation1$125
E.R. Squibb & Sons, L.L.C.1$125
Boehringer Ingelheim Pharmaceuticals, Inc.1$119
Novo Nordisk Inc1$116

Products named: RYBREVANT, INJECTAFER, DALVANCE, TEVIMBRA, Orserdu, Jakafi, REBLOZYL, Ozempic.

Industry payments across NY — which companies pay providers there.